Kairos portfolio company, Compellon, appointed software and services veteran Carv Moore as its Chief Executive Officer to lead the...

Read more
By: Kairos Ventures On: June 15, 2017 In: Delpor

The NIDDK continues to fund Delpor's efforts to utilize its NANOPOR™ technology in developing a matchstick-size subcutaneous implant device...

Read more
By: Kairos Ventures On: June 11, 2017 In: Kairos News

We are happy to announce that Travis Blake has joined the Kairos team as the Principal for Physical Sciences,...

Read more
By: Kairos Ventures On: May 31, 2017 In: Delpor, Portfolio News

Delpor will be part of the Innovation Zone, a high profile 6,000 square foot exhibit space dedicated to showcasing...

Read more
By: Kairos Ventures On: May 9, 2017 In: Holoclara, Portfolio News

This Seed funding allows Holoclara to continue development of their immunotherapy to bring relief to millions of people suffering...

Read more
By: Kairos Ventures On: March 22, 2017 In: Neuro-Bio, Portfolio News

We are pleased to announce that Neuro-Bio is the latest company to join the Kairos portfolio, following our investment...

Read more
By: Kairos Ventures On: March 15, 2017 In: Kairos News

We are delighted to announce that Nikos Iatropoulos will be joining the Kairos team as Head of Operations. In...

Read more
By: Kairos Ventures On: March 10, 2017 In: Kairos News

We would like to extend a warm welcome to three new Investment Associates joining the Kairos team: Adnan Husain,...

Read more
By: Kairos Ventures On: March 7, 2017 In: Delpor, Portfolio News

We are delighted to announce that our portfolio company Delpor has been issued another patent by the United States...

Read more
By: Kairos Ventures On: February 9, 2017 In: Delpor, Portfolio News

Congratulations to our portfolio company Delpor for receiving a new grant award from the National Institute of Mental Health.  The...

Read more